The Claim

Small apolipoprotein(a) isoforms are associated with longevity in French centenarians, indicating that this genetic variant linked to increased lipoprotein(a) production does not reduce lifespan despite its known cardiovascular risk.

Source: Elevated lipoprotein(a) levels and small apo(a) isoforms are compatible with longevity: evidence from a large population of French centenarians.

What the research says

Supports is higher

Support is ahead, but a single strong opposing study can change this.

Supports
20score
Challenges
0score

These are independent scores, not a percentage. Higher-grade studies count more, so a single strong opposing study can outweigh several weaker ones.

Correlation
1 study reviewed
In plain English

A certain genetic trait that usually raises heart disease risk doesn't seem to shorten life in very old French people, showing it might not always be bad for living a long life.

See the scientific wording

Small apolipoprotein(a) isoforms are compatible with longevity in French centenarians, suggesting that this genetic variant associated with higher Lp(a) production does not necessarily reduce lifespan despite its cardiovascular risk implications.

What the research says

1 study

  1. Study: Elevated lipoprotein(a) levels and small apo(a) isoforms are compatible with longevity: evidence from a large population of French centenarians.

    The study looked at the same genetic trait in the same group of very old people and found that having this trait doesn't stop them from living a long life, which matches the claim exactly.

Score breakdown, mechanism chain, raw evidence, ideal studies needed & 1 supporting studies

Fit Body Science verdict — we translate health claims into clear verdicts backed by peer-reviewed research.

Not medical advice. For informational purposes only. Always consult a qualified healthcare professional before making health decisions.